Former Names C57BL/6-Tg(Cxcl4-cre)Q3Rsko/J (Changed: 05-MAR-09 ) Type Coisogenic; Transgenic; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Mating System Noncarrier x Hemizygote (Female x Male) 15-JAN-09 Species laboratory mouse Generation F?+F6 (06-JAN-11)
Generation DefinitionsDonating Investigator Radek Skoda, University Hospital Basel Description
These transgenic mice express a codon-improved Cre recombinase (iCre) under the control of the mouse Pf4 (platelet factor 4), or Cxcl4, promoter. Cre recombinase expression is detected in the majority of megakaryocytes. Mice homozygous for the transgenic insert are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. The BAC clone used to generate this strain also contains 4 other genes: Cxcl5, Cxcl7, Cxcl15 and Cxcl3. The additional copy of these chemokine genes in the BAC has no effect on blood count of the mutant mice. This strain represents an effective tool for generating megakaryocyte lineage-restricted specific-targeted mutants.Development
A 100kb BAC containing the mouse Pf4 (platelet factor 4), or Cxcl4, gene with exon 1 replaced by a construct containing the mouse Pf4 (platelet factor 4), or Cxcl4, promoter, a codon-improved Cre recombinase (iCre) sequence, bovine growth hormone polyadenylation signal, nuclear localization signal and a myc tag was injected into fertilized C57BL/6 fertilized oocytes. Founder line Q3 was established, carrying 1 copy of the transgene. Founder animals were maintained as hemizygotes on the C57BL/6 background.A 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. While the 27 markers throughout the genome suggested a C57BL/6 genetic background, 2 of 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating. These data suggest the mice sent to The Jackson Laboratory Repository were on a C57BL/6N genetic background.
| Control | ||
|---|---|---|
| Noncarrier | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Pf4
007243 B6;SJL-Tg(Cxcl4-F5)1Dgi/J View Strains carrying other alleles of Pf4 (1 strain)
Strains carrying other alleles of cre
004337 129(Cg)-Foxg1tm1(cre)Skm/J 008569 129-Alpltm1(cre)Nagy/J 005989 129;FVB-Tg(PTH-cre)4167Slib/J 007179 129S.Cg-Tg(UBC-cre/ERT2)1Ejb/J 007915 129S.FVB-Tg(Amh-cre)8815Reb/J 003328 129S/Sv-Tg(Prm-cre)58Og/J 004302 129S1/Sv-Hprttm1(cre)Mnn/J 003960 129S6-Tg(Prnp-GFP/cre)1Blw/J 008523 129S6.Cg-Tg(NPHS2-cre)295Lbh/BroJ 012695 B6(129S4)-Et(EGFP/cre)16053Rdav/Mmmh 012696 B6(129S4)-Et(EGFP/cre)16055Rdav/Mmmh 012697 B6(129S4)-Et(EGFP/cre)16059Rdav/Mmmh 012698 B6(129S4)-Et(EGFP/cre)16102Rdav/Mmmh 012699 B6(129S4)-Et(EGFP/cre)16218Rdav/Mmmh 012700 B6(129S4)-Et(EGFP/cre)16250Rdav/Mmmh 012701 B6(129S4)-Et(EGFP/cre)16255Rdav/Mmmh 012702 B6(129S4)-Et(EGFP/cre)16261Rdav/Mmmh 012703 B6(129S4)-Et(EGFP/cre)16279Rdav/Mmmh 009575 B6(129S4)-Et(cre/ERT2)119Rdav/J 009580 B6(129S4)-Et(cre/ERT2)1382Rdav/J 012688 B6(129S4)-Et(cre/ERT2)13866Rdav/J 009581 B6(129S4)-Et(cre/ERT2)1642Rdav/J 009582 B6(129S4)-Et(cre/ERT2)1645Rdav/J 009583 B6(129S4)-Et(cre/ERT2)1957Rdav/J 009584 B6(129S4)-Et(cre/ERT2)2007Rdav/J 009585 B6(129S4)-Et(cre/ERT2)2047Rdav/J 009574 B6(129S4)-Et(cre/ERT2)21Rdav/J 009577 B6(129S4)-Et(cre/ERT2)296Rdav/J 009578 B6(129S4)-Et(cre/ERT2)398Rdav/J 009573 B6(129S4)-Et(cre/ERT2)4Rdav/J 010688 B6(129S4)-Et(cre/ERT2)6691Rdav/J 010689 B6(129S4)-Et(cre/ERT2)6959Rdav/J 010690 B6(129S4)-Et(cre/ERT2)7089Rdav/J 010691 B6(129S4)-Et(cre/ERT2)7149Rdav/J 010692 B6(129S4)-Et(cre/ERT2)7381Rdav/J 010693 B6(129S4)-Et(cre/ERT2)8120Rdav/J 010694 B6(129S4)-Et(cre/ERT2)8131Rdav/J 009579 B6(129S4)-Et(cre/ERT2)837Rdav/J 010695 B6(129S4)-Et(cre/ERT2)9699Rdav/J 009587 B6(129S4)-Et(icre)1402Rdav/J 009588 B6(129S4)-Et(icre)1470Rdav/J 009589 B6(129S4)-Et(icre)1555Rdav/J 009586 B6(129S4)-Et(icre)754Rdav/J 010696 B6(129S4)-Et(icre/ERT2)10596Rdav/J 010697 B6(129S4)-Et(icre/ERT2)10727Rdav/J 012689 B6(129S4)-Et(icre/ERT2)14163Rdav/J 012690 B6(129S4)-Et(icre/ERT2)14208Rdav/J 012694 B6(129S4)-Et(icre/ERT2)14915Rdav/J 012687 B6(129S4)-Tg(SYN1-icre/mRFP1)9934Rdav/J 010774 B6(Cg)-Calb2tm1(cre)Zjh/J 013730 B6(Cg)-Calb2tm2.1(cre/ERT2)Zjh/J 012710 B6(Cg)-Ccktm2.1(cre/ERT2)Zjh/J 010776 B6(Cg)-Lhx6tm1(cre/ERT2)Zjh/J 010777 B6(Cg)-Pvalbtm1(cre/ERT2)Zjh/J 010708 B6(Cg)-Ssttm1(cre/ERT2)Zjh/J 016223 B6(Cg)-Tg(Phox2b-cre)3Jke/J 008463 B6.129-Gt(ROSA)26Sortm1(cre/ERT2)Tyj/J 008320 B6.129-Leprtm2(cre)Rck/J 005697 B6.129-Otx1tm4(cre)Asim/J 004146 B6.129-Tg(Pcp2-cre)2Mpin/J 008710 B6.129P2(129S4)-Hprttm10(Ple162-EGFP/cre)Ems/Mmjax 008877 B6.129P2(129S4)-Hprttm12(Ple177-EGFP/cre)Ems/Mmjax 008709 B6.129P2(129S4)-Hprttm9(Ple178-EGFP/cre)Ems/Mmjax 006785 B6.129P2(C)-Cd19tm1(cre)Cgn/J 006084 B6.129P2(Cg)-Foxg1tm1(cre)Skm/J 010611 B6.129P2(Cg)-Ighg1tm1(IRES-cre)Cgn/J 008875 B6.129P2-Lgr5tm1(cre/ERT2)Cle/J 004781 B6.129P2-Lyz2tm1(cre)Ifo/J 013594 B6.129S-Atoh1tm5.1(Cre/PGR)Hzo/J 006600 B6.129S1-Mnx1tm4(cre)Tmj/J 005628 B6.129S2-Emx1tm1(cre)Krj/J 003755 B6.129S4-Meox2tm1(cre)Sor/J 007893 B6.129S4-Myf5tm3(cre)Sor/J 005623 B6.129S6-Shhtm2(cre/ERT2)Cjt/J 006878 B6.129S6-Taglntm2(cre)Yec/J 012839 B6.129X1(Cg)-Tnfrsf4tm2(cre)Nik/J 008712 B6.129X1-Twist2tm1.1(cre)Dor/J 006054 B6.C-Tg(CMV-cre)1Cgn/J 009642 B6.Cg(129)-Tg(Gh1-cre)1Sac/J 013590 B6.Cg-Braftm1Mmcm Ptentm1Hwu Tg(Tyr-cre/ERT2)13Bos/BosJ 006230 B6.Cg-Cebpatm1Dgt Tg(Mx1-cre)1Cgn/J 012358 B6.Cg-Pvalbtm1.1(cre)Aibs/J 005622 B6.Cg-Shhtm1(EGFP/cre)Cjt/J 017346 B6.Cg-Tg(A930038C07Rik-cre)1Aibs/J 006149 B6.Cg-Tg(ACTA1-cre)79Jme/J 003574 B6.Cg-Tg(Alb-cre)21Mgn/J 006881 B6.Cg-Tg(Aqp2-cre)1Dek/J 011104 B6.Cg-Tg(Atoh1-cre)1Bfri/J 004682 B6.Cg-Tg(CAG-cre/Esr1*)5Amc/J 008520 B6.Cg-Tg(CD2-cre)4Kio/J 009350 B6.Cg-Tg(CDX2-cre)101Erf/J 009352 B6.Cg-Tg(CDX2-cre*)189Erf/J 005359 B6.Cg-Tg(Camk2a-cre)T29-1Stl/J 012237 B6.Cg-Tg(Cdh16-cre)91Igr/J 006137 B6.Cg-Tg(Cdh5-cre)7Mlia/J 016241 B6.Cg-Tg(Col1a1-cre/ERT2)1Crm/J 016237 B6.Cg-Tg(Col1a2-cre/ERT)7Cpd/J 006368 B6.Cg-Tg(Cr2-cre)3Cgn/J 008538 B6.Cg-Tg(Cspg4-cre/Esr1*)BAkik/J 006663 B6.Cg-Tg(Eno2-cre)39Jme/J 005069 B6.Cg-Tg(Fabp4-cre)1Rev/J 012849 B6.Cg-Tg(GFAP-cre/ERT2)505Fmv/J 012886 B6.Cg-Tg(Gfap-cre)73.12Mvs/J 012887 B6.Cg-Tg(Gfap-cre)77.6Mvs/J 003573 B6.Cg-Tg(Ins2-cre)25Mgn/J 008068 B6.Cg-Tg(Itgax-cre)1-1Reiz/J 008781 B6.Cg-Tg(Kap-cre)29066/2Sig/J 012837 B6.Cg-Tg(Lck-cre)3779Nik/J 003802 B6.Cg-Tg(Lck-cre)548Jxm/J 006889 B6.Cg-Tg(Lck-cre)I540Jxm/J 009643 B6.Cg-Tg(Lhb-cre)1Sac/J 003556 B6.Cg-Tg(Mx1-cre)1Cgn/J 007742 B6.Cg-Tg(Myh11-cre,-EGFP)2Mik/J 008205 B6.Cg-Tg(NPHS2-cre)295Lbh/J 003771 B6.Cg-Tg(Nes-cre)1Kln/J 010536 B6.Cg-Tg(Pcp2-cre)3555Jdhu/J 005975 B6.Cg-Tg(Plp1-cre/ERT)3Pop/J 008827 B6.Cg-Tg(Prdm1-cre)1Masu/J 005584 B6.Cg-Tg(Prrx1-cre)1Cjt/J 003967 B6.Cg-Tg(Rbp3-cre)528Jxm/J 008454 B6.Cg-Tg(Sox2-cre)1Amc/J 006361 B6.Cg-Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/J 003966 B6.Cg-Tg(Syn1-cre)671Jxm/J 017491 B6.Cg-Tg(Tagln-cre)1Her/J 004128 B6.Cg-Tg(Tek-cre)12Flv/J 008863 B6.Cg-Tg(Tek-cre)1Ywa/J 008601 B6.Cg-Tg(Th-cre)1Tmd/J 007606 B6.Cg-Tg(Thy1-cre/ERT2,-EYFP)AGfng/J 012328 B6.Cg-Tg(Tyr-cre/ERT2)13Bos/J 008085 B6.Cg-Tg(UBC-cre/ERT2)1Ejb/J 008610 B6.Cg-Tg(Vav1-cre)A2Kio/J 008735 B6.Cg-Tg(Wap-cre)11738Mam/JKnwJ 009614 B6.Cg-Tg(Wfs1-cre/ERT2)2Aibs/J 009107 B6.Cg-Tg(Wnt1-cre)11Rth Tg(Wnt1-GAL4)11Rth/J 006234 B6.Cg-Tg(tetO-cre)1Jaw/J 016832 B6.FVB(129)-Tg(Alb1-cre)1Dlr/J 005657 B6.FVB(129)-Tg(Myh6-cre/Esr1*)1Jmk/J 006475 B6.FVB(129S4)-Tg(Ckmm-cre)5Khn/J 006451 B6.FVB(129X1)-Tg(Sim1-cre)1Lowl/J 006333 B6.FVB(Cg)-Tg(Neurog3-cre)C1Able/J 014643 B6.FVB-Tg(CMA1-cre)6Thhe/J 003724 B6.FVB-Tg(EIIa-cre)C5379Lmgd/J 011069 B6.FVB-Tg(Gh1-cre)bKnmn/J 011038 B6.FVB-Tg(Myh6-cre)2182Mds/J 010714 B6.FVB-Tg(Pomc-cre)1Stl/J 017535 B6.FVB-Tg(Slc32a1-cre)2.1Hzo/FrkJ 003394 B6.FVB-Tg(Zp3-cre)3Mrt/J 014579 B6.NOD-Tg(Foxp3-EGFP/cre)1aJbs/J 006660 B6.SJL-Slc6a3tm1.1(cre)Bkmn/J 004586 B6.SJL-Tg(Vil-cre)997Gum/J 003552 B6129-Tg(Wap-cre)11738Mam/J 010531 B6;129-Bmi1tm1(cre/ERT)Mrc/J 008364 B6;129-Chattm1(cre/ERT)Nat/J 004847 B6;129-Gt(ROSA)26Sortm1(cre/ERT)Nat/J 010528 B6;129-Myf6tm2(cre)Mrc/J 008363 B6;129-Nefltm1(cre/ERT)Nat/J 005549 B6;129-Pax3tm1(cre)Joe/J 009600 B6;129-Six2tm3(EGFP/cre/ERT2)Amc/J 008531 B6;129-Vamp2tm1(cre/ERT)Nat/J 010988 B6;129P-Cyp11a1tm1(GFP/cre)Pzg/J 008529 B6;129P-Tg(Neurog1-cre/ERT2)1Good/J 007770 B6;129P2-Aicdatm1(cre)Mnz/J 006668 B6;129P2-Omptm4(cre)Mom/MomJ 008069 B6;129P2-Pvalbtm1(cre)Arbr/J 007001 B6;129S-Tg(UBC-cre/ERT2)1Ejb/J 009388 B6;129S1-Osr2tm2(cre)Jian/J 009576 B6;129S4-Et(cre/ERT2)278Rdav/J 006410 B6;129S6-Chattm1(cre)Lowl/J 012362 B6;129S6-Tg(Camk2a-cre/ERT2)1Aibs/J 009616 B6;C3-Tg(A930038C07Rik-cre)4Aibs/J 012433 B6;C3-Tg(ACTA1-rtTA,tetO-cre)102Monk/J 008844 B6;C3-Tg(Ctgf-cre)2Aibs/J 008839 B6;C3-Tg(Cyp39a1-cre)1Aibs/J 009117 B6;C3-Tg(Cyp39a1-cre)7Aibs/J 008848 B6;C3-Tg(Mybpc1-cre)2Aibs/J 009111 B6;C3-Tg(Scnn1a-cre)1Aibs/J 009112 B6;C3-Tg(Scnn1a-cre)2Aibs/J 009613 B6;C3-Tg(Scnn1a-cre)3Aibs/J 009103 B6;C3-Tg(Wfs1-cre/ERT2)3Aibs/J 014647 B6;CBA-Tg(Pdx1-cre)6Cvw/J 003466 B6;D2-Tg(Sycp1-cre)4Min/J 014160 B6;DBA-Tg(S100b-EGFP/cre/ERT2)22Amc/J 014159 B6;DBA-Tg(Tmem100-EGFP/cre/ERT2)30Amc/J 015855 B6;DBA-Tg(Upk3a-GFP/cre/ERT2)26Amc/J 010803 B6;FVB-Tg(Adipoq-cre)1Evdr/J 008533 B6;FVB-Tg(Cspg4-cre)1Akik/J 003734 B6;FVB-Tg(GZMB-cre)1Jcb/J 004426 B6;SJL-Tg(Cga-cre)3Sac/J 003554 B6;SJL-Tg(Col2a1-cre)1Bhr/J 005249 B6;SJL-Tg(Krt1-15-cre/PGR)22Cot/J 013094 B6;SJL-Tg(Sox10-cre)507Mcln/J 007610 B6;SJL-Tg(Thy1-cre/ERT2,-EYFP)VGfng/J 007252 B6Ei.129S4-Tg(Prm-cre)58Og/EiJ 017310 B6N.Cg-Tg(Hsd17b1-icre/ERT2)3Casa/J 010550 B6N.FVB-Tg(Penk-glc-2-cre/ERT2)2And/J 003465 BALB/c-Tg(CMV-cre)1Cgn/J 012641 BALB/c-Tg(S100a4-cre)1Egn/YunkJ 010612 C.129P2(Cg)-Ighg1tm1(IRES-cre)Cgn/J 004126 C.Cg-Cd19tm1(cre)Cgn Ighb/J 005673 C.Cg-Tg(Mx1-cre)1Cgn/J 006244 C.Cg-Tg(tetO-cre)1Jaw/J 009155 C57BL/6-Cldn6tm1(cre)Dkwu/J 017557 C57BL/6-Tg(BEST1-cre)1Jdun/J 016097 C57BL/6-Tg(Car1-cre)5Flt/J 011086 C57BL/6-Tg(Cck-cre)CKres/J 008766 C57BL/6-Tg(Cd8a-cre)1Itan/J 006474 C57BL/6-Tg(Grik4-cre)G32-4Stl/J 008314 C57BL/6-Tg(HBB-cre)12Kpe/J 008870 C57BL/6-Tg(Hspa2-cre)1Eddy/J 016261 C57BL/6-Tg(Nes-cre/ERT2)KEisc/J 012906 C57BL/6-Tg(Nes-cre/Esr1*)1Kuan/J 016617 C57BL/6-Tg(Nr4a1-EGFP/cre)820Khog/J 013148 C57BL/6-Tg(Pdgfra-cre)1Clc/J 006888 C57BL/6-Tg(Zp3-cre)1Gwh/J 003651 C57BL/6-Tg(Zp3-cre)93Knw/J 007567 C57BL/6J-Tg(Itgax-cre,-EGFP)4097Ach/J 008661 C57BL/6J-Tg(Nkx2-1-cre)2Sand/J 003650 C57BL/6J-Tg(Zp3-cre)82Knw/KnwJ 012686 C57BL/6N-Tg(Ppp1r2-cre)4127Nkza/J 016582 C57BL/6N-Tg(Slc32a1-icre/ERT2)3Gloss/J 016583 C57BL/6N-Tg(Slc6a3-icre/ERT2)2Gloss/J 016833 FVB(Cg)-Tg(Alb1-cre)1Dlr/J 011034 FVB(Cg)-Tg(Ghrhr-cre)3242Lsk/J 006405 FVB-Tg(Ckmm-cre)5Khn/J 006774 FVB-Tg(Col2a1-cre/ERT)KA3Smac/J 006954 FVB-Tg(Ddx4-cre)1Dcas/J 004600 FVB-Tg(GFAP-cre)25Mes/J 011037 FVB-Tg(Myh6-cre)2182Mds/J 006364 FVB-Tg(Nr5a1-cre)2Lowl/J 008537 FVB-Tg(Tek-cre)2352Rwng/J 006139 FVB.Cg-Tg(ACTA1-cre)79Jme/J 006297 FVB.Cg-Tg(Eno2-cre)39Jme/J 008244 FVB.Cg-Tg(tetO-cre)1Jaw/J 003376 FVB/N-Tg(ACTB-cre)2Mrt/J 003314 FVB/N-Tg(EIIa-cre)C5379Lmgd/J 006143 FVB/N-Tg(Thy1-cre)1Vln/J 003377 FVB/N-Tg(Zp3-cre)3Mrt/J 013233 NOD.B6-Tg(Itgax-cre,-EGFP)4097Ach/J 005732 NOD.Cg-Tg(Lck-cre)548Jxm/AchJ 013251 NOD.FVB-Tg(EIIa-cre)C5379Lmgd/J 008694 NOD/ShiLt-Tg(Foxp3-EGFP/cre)1cJbs/J 004986 NOD/ShiLt-Tg(Ins2-cre)3Lt/LtJ 003855 NOD/ShiLt-Tg(Ins2-cre)5Lt/LtJ 004987 NOD/ShiLt-Tg(Ins2-cre)6Lt/LtJ 012899 STOCK Agrptm1(cre)Lowl/J 012882 STOCK Ascl1tm1.1(Cre/ERT2)Jejo/J 007916 STOCK En1tm2(cre)Wrst/J 007917 STOCK En1tm7(cre/ESR1)Alj/J 007924 STOCK En2tm4(cre/ERT2)Alj/J 008464 STOCK Foxa2tm2.1(cre/Esr1*)Moon/J 007913 STOCK Gli1tm3(cre/ERT2)Alj/J 008876 STOCK Hprttm11(Ple176-EGFP/cre)Ems/Mmjax 007022 STOCK Mnx1tm4(cre)Tmj Smn1tm1Msd Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb/J 004192 STOCK Mttptm2Sgy Ldlrtm1Her Apobtm2Sgy Tg(Mx1-cre)1Cgn/J 006953 STOCK Notch1tm3(cre)Rko/J 006677 STOCK Olfr151tm28(cre)Mom/MomJ 009061 STOCK Osr1tm1(EGFP/cre/ERT2)Amc/J 012719 STOCK Tgfb3tm1(cre)Vk/J 012620 STOCK Trp53tm1Brd Brca1tm1Aash Tg(LGB-cre)74Acl/J 008813 STOCK Trpa1tm2Kykw Tg(CAG-cre/Esr1*)5Amc/J 010911 STOCK Wt1tm1(EGFP/cre)Wtp/J 012691 STOCK Et(icre/ERT2)14374Rdav/J 012692 STOCK Et(icre/ERT2)14602Rdav/J 012693 STOCK Et(icre/ERT2)14624Rdav/J 007684 STOCK Tg(Atoh1-cre/Esr1*)14Fsh/J 004453 STOCK Tg(CAG-cre/Esr1*)5Amc/J 009615 STOCK Tg(Cartpt-cre)1Aibs/J 005105 STOCK Tg(Chx10-EGFP/cre,-ALPP)2Clc/J 008861 STOCK Tg(Ela1-Cre/ERT2)1Stof/J 008852 STOCK Tg(En2-cre)22Alj/J 005938 STOCK Tg(Eno2-cre)39Jme/J 011062 STOCK Tg(Gdf9-cre)5092Coo/J 012841 STOCK Tg(Ggt1-cre)M3Egn/J 004692 STOCK Tg(Hoxb7-cre)13Amc/J 014600 STOCK Tg(I12b-cre/ERT2,-ALPP)37Fsh/J 008122 STOCK Tg(Ins2-cre/ERT)1Dam/J 004782 STOCK Tg(KRT14-cre)1Amc/J 005107 STOCK Tg(KRT14-cre/ERT)20Efu/J 008582 STOCK Tg(Kcnc2-Cre)K128Stl/LetJ 003551 STOCK Tg(MMTV-cre)1Mam/J 003553 STOCK Tg(MMTV-cre)4Mam/J 002527 STOCK Tg(Mx1-cre)1Cgn/J 009074 STOCK Tg(Myh6-cre)1Jmk/J 005650 STOCK Tg(Myh6-cre/Esr1*)1Jmk/J 009102 STOCK Tg(Nefh-cre)12Kul/J 002858 STOCK Tg(Nes-cre)1Wme/J 002859 STOCK Tg(Nes-cre)2Wme/J 012859 STOCK Tg(Neurog1-cre)1Jejo/J 005667 STOCK Tg(Neurog3-cre)C1Able/J 008119 STOCK Tg(Neurog3-cre/Esr1*)1Dam/J 012462 STOCK Tg(Nr5a1-cre)7Lowl/J 014158 STOCK Tg(Pax4-cre)1Dam/J 006207 STOCK Tg(Pcp2-cre)1Amc/J 014099 STOCK Tg(Pmch-cre)1Lowl/J 005965 STOCK Tg(Pomc1-cre)16Lowl/J 012452 STOCK Tg(Rr5-GFP/cre)1Sapc/J 006395 STOCK Tg(Sim1-cre)1Lowl/J 009606 STOCK Tg(Six2-EGFP/cre)1Amc/J 012586 STOCK Tg(Slc1a3-cre/ERT)1Nat/J 004783 STOCK Tg(Sox2-cre)1Amc/J 008208 STOCK Tg(Stra8-cre)1Reb/J 016236 STOCK Tg(TCF/Lef1-cre/ERT2)1Dje/J 004746 STOCK Tg(Tagln-cre)1Her/J 012708 STOCK Tg(Thy1-cre/ERT2,-EYFP)HGfng/PyngJ 016584 STOCK Tg(Tph2-icre/ERT2)6Gloss/J 003829 STOCK Tg(Wnt1-cre)11Rth Tg(Wnt1-GAL4)11Rth/J 007807 STOCK Tg(Wnt1-cre)11Rth Tg(Wnt1-GAL4)11Rth/MileJ 008851 STOCK Tg(Wnt1-cre/ERT)1Alj/J 008199 STOCK Tg(dlx6a-cre)1Mekk/J 002471 STOCK Tg(hCMV-cre)140Sau/J 006224 STOCK Tg(tetO-cre)1Jaw/J View Strains carrying other alleles of cre (311 strains)
Introduction to Cre-lox technology
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
cre relatedResearch Tools
Cardiovascular Research
Cre-lox System
Cre-lox System
Cre Recombinase Expression
Research Tools
Cre-lox System
Genetics Research
Mutagenesis and Transgenesis
Mutagenesis and Transgenesis: Cre-lox System
| Allele Symbol | Tg(Pf4-cre)Q3Rsko | ||
|---|---|---|---|
| Allele Name | transgene insertion Q3, Radek C Skoda | ||
| Allele Type | Transgenic (Cre/Flp) | ||
| Common Name(s) | Pf4-Cre; Tg(Cxcl4-cre)Q3Rsko; | ||
| Mutation Made By | Radek Skoda, University Hospital Basel | ||
| Strain of Origin | C57BL/6 | ||
| Site of Expression | Cre is detected in the majority of megakaryocytes. | ||
| Expressed Gene | cre, cre recombinase, bacteriophage P1 | ||
| Cre recombinase is an enzyme derived from the bacteriophage P1 that specifically recognizes loxP sites. Cre has been shown to effectively mediate the excision of DNA located between loxP sites. After the excision event, the DNA ends recombine leaving a single loxP site in place of the intervening sequence. | |||
| Promoter | Pf4, platelet factor 4, mouse, laboratory | ||
| Driver Note | Pf4 | ||
| Molecular Note | A transgene was created from a BAC where cre-recombinase is driven by the Cxcl4 (Platelet factor 4) promoter. This transgene also contains the Cxcl3, Cxcl5, Ppbp, and Cxcl15 genes. This line has one copy of the transgene inserted with expression restricted to megakaryocytes and platelets, as demonstrated by RT-PCR and Western blotting. [MGI Ref ID J:127229] | ||
| Gene Symbol and Name | Tg(Pf4-cre)Q3Rsko, transgene insertion Q3, Radek C Skoda | ||
| Chromosome | UN | ||
| Gene Common Name(s) | Pf4-Cre; Tg(Cxcl4-cre)Q3Rsko; | ||
Genotyping Protocols
Tg(Cxc14-cre), Standard PCR
Helpful Links
Genotyping resources and troubleshooting
Tiedt R; Schomber T; Hao-Shen H; Skoda RC. 2007. Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood 109(4):1503-6. [PubMed: 17032923] [MGI Ref ID J:127229]
Tg(Pf4-cre)Q3Rsko relatedBender M; Eckly A; Hartwig JH; Elvers M; Pleines I; Gupta S; Krohne G; Jeanclos E; Gohla A; Gurniak C; Gachet C; Witke W; Nieswandt B. 2010. ADF/n-cofilin-dependent actin turnover determines platelet formation and sizing. Blood 116(10):1767-75. [PubMed: 20530287] [MGI Ref ID J:164521]
Bender M; Hofmann S; Stegner D; Chalaris A; Bosl M; Braun A; Scheller J; Rose-John S; Nieswandt B. 2010. Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood 116(17):3347-55. [PubMed: 20644114] [MGI Ref ID J:165863]
Bertozzi CC; Schmaier AA; Mericko P; Hess PR; Zou Z; Chen M; Chen CY; Xu B; Lu MM; Zhou D; Sebzda E; Santore MT; Merianos DJ; Stadtfeld M; Flake AW; Graf T; Skoda R; Maltzman JS; Koretzky GA; Kahn ML. 2010. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 116(4):661-70. [PubMed: 20363774] [MGI Ref ID J:162815]
Bhavaraju K; Lakhani PR; Dorsam RT; Jin J; Hitchcock IS; Sanjay A; Kunapuli SP. 2011. G(12/13) signaling pathways substitute for integrin alphaIIbbeta3-signaling for thromboxane generation in platelets. PLoS One 6(2):e16586. [PubMed: 21347357] [MGI Ref ID J:171092]
Carramolino L; Fuentes J; Garcia-Andres C; Azcoitia V; Riethmacher D; Torres M. 2010. Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis. Circ Res 106(7):1197-201. [PubMed: 20203303] [MGI Ref ID J:171033]
Eckly A; Strassel C; Freund M; Cazenave JP; Lanza F; Gachet C; Leon C. 2009. Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation. Blood 113(14):3182-9. [PubMed: 18984861] [MGI Ref ID J:148137]
Halene S; Gao Y; Hahn K; Massaro S; Italiano JE Jr; Schulz V; Lin S; Kupfer GM; Krause DS. 2010. Serum response factor is an essential transcription factor in megakaryocytic maturation. Blood 116(11):1942-50. [PubMed: 20525922] [MGI Ref ID J:164524]
Haling JR; Monkley SJ; Critchley DR; Petrich BG. 2011. Talin-dependent integrin activation is required for fibrin clot retraction by platelets. Blood 117(5):1719-22. [PubMed: 20971947] [MGI Ref ID J:177971]
Hitchcock IS; Fox NE; Prevost N; Sear K; Shattil SJ; Kaushansky K. 2008. Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout. Blood 111(2):596-604. [PubMed: 17925492] [MGI Ref ID J:130102]
Josefsson EC; James C; Henley KJ; Debrincat MA; Rogers KL; Dowling MR; White MJ; Kruse EA; Lane RM; Ellis S; Nurden P; Mason KD; O'Reilly LA; Roberts AW; Metcalf D; Huang DC; Kile BT. 2011. Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets. J Exp Med 208(10):2017-31. [PubMed: 21911424] [MGI Ref ID J:177288]
Jurak Begonja A; Hoffmeister KM; Hartwig JH; Falet H. 2011. FlnA-null megakaryocytes prematurely release large and fragile platelets that circulate poorly. Blood 118(8):2285-95. [PubMed: 21652675] [MGI Ref ID J:176939]
Kodama T; Takehara T; Hikita H; Shimizu S; Shigekawa M; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Yin XM; Hayashi N. 2011. BH3-only Activator Proteins Bid and Bim Are Dispensable for Bak/Bax-dependent Thrombocyte Apoptosis Induced by Bcl-xL Deficiency: MOLECULAR REQUISITES FOR THE MITOCHONDRIAL PATHWAY TO APOPTOSIS IN PLATELETS. J Biol Chem 286(16):13905-13. [PubMed: 21367852] [MGI Ref ID J:171123]
Leon C; Eckly A; Hechler B; Aleil B; Freund M; Ravanat C; Jourdain M; Nonne C; Weber J; Tiedt R; Gratacap MP; Severin S; Cazenave JP; Lanza F; Skoda R; Gachet C. 2007. Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. Blood 110(9):3183-91. [PubMed: 17664350] [MGI Ref ID J:148233]
Martin V; Guillermet-Guibert J; Chicanne G; Cabou C; Jandrot-Perrus M; Plantavid M; Vanhaesebroeck B; Payrastre B; Gratacap MP. 2010. Deletion of the p110beta isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo. Blood 115(10):2008-13. [PubMed: 20065293] [MGI Ref ID J:158839]
Pawlinski R; Wang JG; Owens AP 3rd; Williams J; Antoniak S; Tencati M; Luther T; Rowley JW; Low EN; Weyrich AS; Mackman N. 2010. Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood 116(5):806-14. [PubMed: 20410508] [MGI Ref ID J:163510]
Pericacho M; Alonso-Martin S; Larrucea S; Gonzalez-Manchon C; Fernandez D; Sanchez I; Ayuso MS; Parrilla R. 2011. Diminished thrombogenic responses by deletion of the Podocalyxin Gene in mouse megakaryocytes. PLoS One 6(10):e26025. [PubMed: 22016802] [MGI Ref ID J:178107]
Petrich BG; Marchese P; Ruggeri ZM; Spiess S; Weichert RA; Ye F; Tiedt R; Skoda RC; Monkley SJ; Critchley DR; Ginsberg MH. 2007. Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med 204(13):3103-11. [PubMed: 18086863] [MGI Ref ID J:129707]
Pleines I; Eckly A; Elvers M; Hagedorn I; Eliautou S; Bender M; Wu X; Lanza F; Gachet C; Brakebusch C; Nieswandt B. 2010. Multiple alterations of platelet functions dominated by increased secretion in mice lacking Cdc42 in platelets. Blood 115(16):3364-73. [PubMed: 20139097] [MGI Ref ID J:160792]
Tan J; Jones M; Koseki H; Nakayama M; Muntean AG; Maillard I; Hess JL. 2011. CBX8, a Polycomb Group Protein, Is Essential for MLL-AF9-Induced Leukemogenesis. Cancer Cell 20(5):563-75. [PubMed: 22094252] [MGI Ref ID J:178955]
Wang Y; Litvinov RI; Chen X; Bach TL; Lian L; Petrich BG; Monkley SJ; Critchley DR; Sasaki T; Birnbaum MJ; Weisel JW; Hartwig J; Abrams CS. 2008. Loss of PIP5KIgamma, unlike other PIP5KI isoforms, impairs the integrity of the membrane cytoskeleton in murine megakaryocytes. J Clin Invest 118(2):812-9. [PubMed: 18188447] [MGI Ref ID J:131289]
Wen Q; Leung C; Huang Z; Small S; Reddi AL; Licht JD; Crispino JD. 2009. Survivin is not required for the endomitotic cell cycle of megakaryocytes. Blood 114(1):153-6. [PubMed: 19339696] [MGI Ref ID J:150314]
Zhang G; Xiang B; Dong A; Skoda RC; Daugherty A; Smyth SS; Du X; Li Z. 2011. Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation. Blood 118(13):3670-9. [PubMed: 21803853] [MGI Ref ID J:177066]
Animal Health Reports
Room Number MGL377
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, these mice can be bred as homozygotes. Mating System Noncarrier x Hemizygote (Female x Male) 15-JAN-09 Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
![]() |
Price (US dollars $) Gender Genotypes Provided Individual Mouse $261.00 Female or Male Hemizygous for Tg(Pf4-cre)Q3Rsko
Pairs /Price (US dollars $) Pair Genotype $321.00 Hemizygous for Tg(Pf4-cre)Q3Rsko x Noncarrier $321.00 Noncarrier x Hemizygous for Tg(Pf4-cre)Q3Rsko Standard Supply
Repository-Live. The Repository Strains represent an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. We treat orders for these strains as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
| Pricing for International shipping destinations |
|
![]() |
Price (US dollars $) Gender Genotypes Provided Individual Mouse $339.30 Female or Male Hemizygous for Tg(Pf4-cre)Q3Rsko
Pairs /Price (US dollars $) Pair Genotype $417.30 Hemizygous for Tg(Pf4-cre)Q3Rsko x Noncarrier $417.30 Noncarrier x Hemizygous for Tg(Pf4-cre)Q3Rsko Standard Supply
Repository-Live. The Repository Strains represent an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. We treat orders for these strains as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
|
|
Repository-Live. The Repository Strains represent an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. We treat orders for these strains as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
| Control | ||
|---|---|---|
| Noncarrier | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.